Allergy/Immunology
RSSArticles
-
COVID-19 Rebound
Symptomatic and virologic recrudescence after treatment of patients with COVID-19 with Paxlovid occurs in a tiny percentage of patients and generally is mild and self-limited.
-
COVID-19 Pre-Exposure Prophylaxis
The combination of tixagevimab and cilgavimab (Evusheld) was demonstrated to be effective in the prevention of symptomatic COVID-19, but much remains to be learned as SARS-CoV-2 continues to evolve.
-
Who Can Receive the Non-mRNA COVID-19 Vaccine Now?
The FDA recently limited the use of the Janssen COVID-19 vaccine.
-
Ethical Precision Medicine Requires Relying on Scientific Evidence, Safeguarding Information
American College of Physicians offers guidance as genome sequencing technology progresses quickly.
-
Two-Dose Novavax Added to List of U.S. COVID-19 Vaccines
The FDA issued an emergency use authorization for the fourth vaccine.
-
Long COVID Patients Report Symptoms 15 Months Later
Brain fog, dizziness, and more side effects can linger for many months after initial SARS-CoV-2 infection.
-
Experts Urge ED Leaders to Refocus Efforts on Antimicrobial Stewardship
Early advocates of antimicrobial stewardship tended to focus on prescribing in outpatient settings. In recent years, attention has shifted toward the ED — and there are many good reasons for this shift.
-
Long-Term Care Facilities Cut Superfluous Antibiotic Use
Locations that adhered to federal safety program reported more success in this area.
-
AMA Asks to Remove Prescription Status from Naloxone
The request was made in the wake of a study that revealed expanded access to the opioid reversal agent is needed in almost every U.S. state.
-
Third Documented HIV Remission Case Emerges
Woman with acute myeloid leukemia underwent stem cell transplant, which apparently sent the virus into remission.